<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2024.1533816</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Clinical Trial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Changes in gut microbiota after gastric cancer surgery: a prospective longitudinal study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>He</surname>
<given-names>Yuhua</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Gao</surname>
<given-names>Shilin</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2513336"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Lili</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Colorectal Cancer Center, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University</institution>, <addr-line>Chengdu, Sichuan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Georgia Damoraki, National and Kapodistrian University of Athens, Greece</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Marcos Edgar Herkenhoff, University of S&#xe3;o Paulo, Brazil</p>
<p>Vasiliki Bourika, National and Kapodistrian University of Athens, Greece</p>
<p>Spyros Foutadakis, Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jie Yang, <email xlink:href="mailto:myjamie@126.com">myjamie@126.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1533816</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 He, Gao, Jiang and Yang</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>He, Gao, Jiang and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>This study was designed to characterize gut microbiota changes of the patients with gastric cancer before and after the gastrectomy during their hospital staying periods.</p>
</sec>
<sec>
<title>Methods</title>
<p>16S ribosomal RNA (rRNA) gene sequencing was used to evaluate differences in gut microbiota among patients with gastric cancer before and after the gastrectomy by comparing gut microbiota &#x3b1; diversity, &#x3b2; diversity, and structure composition at different taxonomic levels.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 120 fecal specimens were collected from 60 patients. There was no significant difference in Chao1 index, Shannon index, and Simpson index before and after gastrectomy (all <italic>P</italic> &gt; 0.05). At the phylum level, the gut microbiota in the gastrectomy group showed less abundance of <italic>Bacteroidota</italic>, <italic>Synergistota</italic>, and <italic>Verrucomicrobiota</italic> but with higher abundance of <italic>Campylobacter</italic>, <italic>Actinobacteria</italic>, and <italic>Bacillota</italic>. At the genus level, the gut microbiota in the gastrectomy group showed less abundance of flora <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Blautia</italic>, and <italic>Lachnospiraceae nk4a136</italic> group but with higher abundance of <italic>Campylobacter</italic>, <italic>Porphyromona</italic>, <italic>Finegordia</italic>, <italic>Dialist</italic>, <italic>Anaerococcus</italic>, and <italic>Corynebacterium.</italic>
</p>
</sec>
<sec>
<title>Conclusions</title>
<p>There was no significant change in the diversity of intestinal flora before and after surgery. However, significant changes in the structure of intestinal flora before and after surgery were occurred.</p>
</sec>
</abstract>
<kwd-group>
<kwd>gastric cancer</kwd>
<kwd>gut microbiota</kwd>
<kwd>high-throughput sequencing</kwd>
<kwd>surgery</kwd>
<kwd>bacteria</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="32"/>
<page-count count="10"/>
<word-count count="3144"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Gastrointestinal Cancers: Gastric and Esophageal Cancers</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Gastric cancer (GC) is a global health issue, being the fifth most prevalent cancer and the third leading cause of neoplasm death worldwide (<xref ref-type="bibr" rid="B1">1</xref>). China is experiencing a transition in its cancer profiles, with greater incidence of cancers (<xref ref-type="bibr" rid="B2">2</xref>). Gastrectomy as a curative resection for GC aims to obtain complete histopathological clearance and involves radical resection of the primary site, as well as resection of affected lymph nodes and adjacent organs if necessary (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>The human gastrointestinal (GI) tract is a complex micro-ecosystem inhabited by as many as 10<sup>14</sup> microorganisms, including bacteria, fungi, viruses, and protozoa (<xref ref-type="bibr" rid="B4">4</xref>). There are more than 400 species of bacteria in the intestinal microecology of the human body, of which the predominant flora mainly includes <italic>Bacteroides</italic> and <italic>Bacillota</italic>, which account for more than 70% of the total number of bacteria, and other bacteria mainly include <italic>Proteobacteria</italic>, <italic>Clostridium</italic>, <italic>Actinomycetes</italic>, <italic>Warts Microbacteria</italic>, and <italic>Cyanobacteria</italic> (<xref ref-type="bibr" rid="B5">5</xref>). Different intestinal flora jointly maintain the dynamic balance of the micro-ecosystem by restricting each other and participate in the body&#x2019;s energy conversion, metabolism, digestion, immune regulation, and intestinal mucosal barrier defense functions (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>With the technology of 16S rRNA gene sequence analysis, the changes of intestinal flora in patients undergoing gastrectomy during the perioperative period are gradually revealed. An increased gut microbial diversity and an altered microbial composition in conjunction with the metabolic improvements were found after Roux-en-Y gastric bypass (RYGB) (<xref ref-type="bibr" rid="B9">9</xref>). Furthermore, colonization of germ-free mice with fecal material from RYGB-operated mice caused weight loss and reduced adiposity, providing evidence that RYGB-associated gut microbiota can improve host metabolism (<xref ref-type="bibr" rid="B10">10</xref>). These clinical studies have shown major changes microbiota after gastrectomy, whereas most of the subjects were patients with obesity or mice undergoing RYGB surgery.</p>
<p>Different from the previous studies, patients with GC face multiple clinical exposure factors during the perioperative period, including antibiotics, diet, anxiety, and hospital pathogens, which will affect the intestinal flora (<xref ref-type="bibr" rid="B11">11</xref>). However, gut microbiota changes in patients with GC in perioperative period are little understood. In addition, intestinal microbiota may also be further affected in patients with GC due to reconstruction of digestive tract and reduction of tumor burden (<xref ref-type="bibr" rid="B12">12</xref>). Liang et&#xa0;al. first reported the impact of radical distal gastrectomy on the fecal microbiota of patients with GC and found that radical distal gastrectomy had a significant impact on the intestinal microbiota community composition, mainly manifested in the changes in the relative abundance of <italic>Achmania</italic>, <italic>Escherichia/Shigella</italic>, <italic>Lactobacillus</italic>, and <italic>Microbacillus</italic> (<xref ref-type="bibr" rid="B11">11</xref>). However, the sample size of this study was only six cases.</p>
<p>This study was designed to characterize fecal microbiota shifts in GC before and after surgery during their hospital staying periods.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s3_1">
<label>2.1</label>
<title>Study design</title>
<p>This is a before-and-after study in the same patient, which is designed to characterize fecal microbiota shifts in GC before and after surgery during their hospital staying periods, and has been reported in line with the Strengthening the reporting of cohort studies in surgery (STROCSS) criteria.</p>
</sec>
<sec id="s3_2">
<label>2.2</label>
<title>Ethical approval</title>
<p>Research ethics were proposed by the Biomedical Ethics Committee of West China Hospital of Sichuan University. After reviewing of the hospital ethics committee, trained study research assistants accomplished informed consent process.</p>
</sec>
<sec id="s3_3">
<label>2.3</label>
<title>Study participants</title>
<p>Study participants were recruited from January 2021 to December 2021 at West China Hospital of Sichuan University. The sample size was determined according to the species accumulation curve. When the sample size increases, the curve tends to be flat, indicating that the sample size meets the requirements. Finally, 60 adult patients were enrolled. Participants provided a written informed consent. The inclusion criteria for participants were as follows: diagnosed with GC by pathological biopsy under gastroscopy before operation; underwent elective gastrectomy; without other metabolic diseases (diabetes, obesity, gout, etc.) and infectious diseases (HIV infection, etc.); and no distant metastasis of liver, lung, bone, etc. Exclusion criteria included the following: a history of GI surgery; administration of probiotics, macrobiotic live preparations, antibiotics, metformin, proton pump inhibitors, berberine, or laxatives in the past 3 months; and preoperative with intestinal inflammation, perforation, obstruction, and severe systemic disease. All patients followed the concept of Enhanced Recovery after Surgery management during perioperative period. All patients fasted for 6 h and abstained from drinking for 2 h before surgery. Non-diabetic patients can take carbohydrate drinks &#x2264;400 mL 2~3 h before surgery. Patients were not given preoperative intervention treatment such as probiotics, macrobiotic live bacteria preparations, antibiotics, proton pump inhibitors, and berberine, laxatives that affect the intestinal flora. Surgeries are performed by doctors in the same medical group.</p>
</sec>
<sec id="s3_4">
<label>2.4</label>
<title>Fecal sample collection</title>
<p>Patients collect their own fecal samples at two time points. The first stool sample is taken the day before surgery. The second sample was from the first natural bowel movement after surgery (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Patients placed the fecal samples directly into clean, dry, and non-absorbent covered container tubes (approximately 1.0 g per tube). The samples were placed in a freezer at &#x2212;80&#xb0;C within 30 min of excretion. Samples were transported to the Yakult Central Institute at &#x2212;20&#xb0;C for analysis for analysis of &#x3b1; diversity, &#x3b2; diversity, and gut microbiota structure composition at different taxonomic levels.</p>
</sec>
<sec id="s3_5">
<label>2.5</label>
<title>DNA extraction and amplification</title>
<p>Bacterial DNA was isolated from the fecal samples using a MagPure Soil/Stool DNA LQ Kit (Magen, Guangdong, China) following the manufacturer&#x2019;s instructions. DNA concentration and integrity were measured by a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and agarose gel electrophoresis, respectively. PCR amplification of the V3-V4 hypervariable regions of the bacterial 16S rRNA gene was carried out in a 25-&#x3bc;L reaction using universal primer pairs (343F: 5&#x2032;-TACGGRAGGCAGCAG-3&#x2032;; 798R: 5&#x2032;-AGGGTATCTAATCCT-3&#x2032;). The reverse primer contained a sample barcode and both primers were connected with an Illumina sequencing adapter.</p>
</sec>
<sec id="s3_6">
<label>2.6</label>
<title>Library construction and sequencing</title>
<p>The amplicon quality was visualized using gel electrophoresis. The PCR products were purified with Agincourt AM Pure XP beads (Beckman Coulter Co., USA) and quantified using a Qubit dsDNA assay kit. The concentrations were then adjusted for sequencing. Sequencing was performed on an Illumina NovaSeq6000 with two paired-end read cycles of 250 bases each. (Illumina Inc., San Diego, CA; OE Biotech Company, Shanghai, China).</p>
</sec>
<sec id="s3_7">
<label>2.7</label>
<title>Bioinformatics analysis</title>
<p>Paired-end reads were preprocessed using Trimmomatic software (<xref ref-type="bibr" rid="B15">15</xref>) to detect and cut off ambiguous bases (N). It also cut off low quality sequences with average quality score below 20 using sliding window trimming approach. After trimming, paired-end reads were assembled using FLASH software (<xref ref-type="bibr" rid="B16">16</xref>). Parameters of assembly were: 10 bp of minimal overlapping, 200 bp of maximum overlapping, and 20% of maximum mismatch rate. Sequences were further denoised as follows: reads with ambiguous, homologous sequences or below 200 bp were abandoned. Reads with 75% of bases above Q20 were retained using QIIME software (version 1.8.0) (<xref ref-type="bibr" rid="B17">17</xref>). Then, reads with chimera were detected and removed using VSEARCH (<xref ref-type="bibr" rid="B18">18</xref>). Clean reads were subjected to primer sequences removal and clustering to generate operational taxonomic units (OTUs) using VSEARCH software with 97% similarity cutoff (<xref ref-type="bibr" rid="B16">16</xref>). The representative read of each OTU was selected using QIIME package. All representative reads were annotated and blasted against Silva database (version 132) using Ribosomal Database Project (RDP) classifier (confidence threshold was 70%) (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>The microbial diversity in fecal samples was estimated using the &#x3b1; diversity that includes Chao1 index (<xref ref-type="bibr" rid="B20">20</xref>), Shannon index (<xref ref-type="bibr" rid="B21">21</xref>), and Simpson index. The Bray&#x2013;Curtis distance matrix performed by QIIME software was used for weighted UniFrac non-metric multidimensional scaling (NMDS). The 16S rRNA gene amplicon sequencing and analysis were conducted by OE Biotech Co., Ltd. (Shanghai, China).</p>
</sec>
<sec id="s3_8">
<label>2.8</label>
<title>Statistical analysis</title>
<p>The difference of &#x3b1;-diversity index in different groups was compared by Wilcoxon rank sum test. Principal coordinate analysis was used to identify overall gut microbial composition between preoperative patients and postoperative patients based on Bray&#x2013;Curtis dissimilarity index. Wilcoxon rank sum was used to test the different species of intestinal flora before and after the operation, and the boxplot map of different species at the level of phylum and genus was drawn.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<p>A flowchart of subject selection (a graphical representation of a process) was performed to illustrate the results of research and the screening process (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flowchart of the study.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g001.tif"/>
</fig>
<sec id="s4_1">
<label>3.1</label>
<title>Collection of 16S results</title>
<p>A total of 120 stool samples from 60 patients were collected. Characteristics of these participants were seen in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The characteristics of participants.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Characteristics</th>
<th valign="top" align="left">Classification</th>
<th valign="top" align="left">N</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="2">Nation</td>
<td valign="top" align="left">The Han nationality</td>
<td valign="top" align="left">57</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="left">3</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Sex</td>
<td valign="top" align="left">Male</td>
<td valign="top" align="left">36</td>
</tr>
<tr>
<td valign="top" align="left">Female</td>
<td valign="top" align="left">24</td>
</tr>
<tr>
<td valign="top" align="left">Age, years, mean &#xb1; SD</td>
<td valign="top" align="left">65.10 &#xb1; 12.21</td>
<td valign="top" align="left">60</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Preoperative comorbidity</td>
<td valign="top" align="left">No</td>
<td valign="top" align="left">5</td>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">55</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Preoperative neoadjuvant chemotherapy</td>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">28</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">32</td>
</tr>
<tr>
<td valign="top" align="left">Gastric tube placed</td>
<td valign="top" align="left">No</td>
<td valign="top" align="left">60</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Surgical approach</td>
<td valign="top" align="left">Laparoscopy</td>
<td valign="top" align="left">19</td>
</tr>
<tr>
<td valign="top" align="left">Open</td>
<td valign="top" align="left">41</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Intraoperative prophylactic antibiotics</td>
<td valign="top" align="left">Cefoxitin sodium, 1 g</td>
<td valign="top" align="left">32</td>
</tr>
<tr>
<td valign="top" align="left">Cefmetazole sodium, 1 g</td>
<td valign="top" align="left">28</td>
</tr>
<tr>
<td valign="top" align="left">Intraoperative blood loss, mL, mean &#xb1; SD</td>
<td valign="top" align="left">52.75 &#xb1; 21.65</td>
<td valign="top" align="left">60</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Digestive tract reconstruction</td>
<td valign="top" align="left">Billroth I</td>
<td valign="top" align="left">16</td>
</tr>
<tr>
<td valign="top" align="left">Billroth II</td>
<td valign="top" align="left">21</td>
</tr>
<tr>
<td valign="top" align="left">Roux-en-Y</td>
<td valign="top" align="left">23</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">Resection range</td>
<td valign="top" align="left">Proximal gastrectomy</td>
<td valign="top" align="left">16</td>
</tr>
<tr>
<td valign="top" align="left">Distal subtotal gastrectomy</td>
<td valign="top" align="left">21</td>
</tr>
<tr>
<td valign="top" align="left">Total gastrectomy</td>
<td valign="top" align="left">23</td>
</tr>
<tr>
<td valign="top" align="left">Surgical duration, hours, mean &#xb1; SD</td>
<td valign="top" align="left">4.72 &#xb1; 0.80</td>
<td valign="top" align="left">60</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="3">ASA</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">2</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="left">28</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="left">30</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The data volume of clean tags for samples is between 12,266 and 78,875 bp. The data volume of clean tags obtained by removing chimeras is between 8,817 and 76,313 bp. The average length of valid tags is between 406.47 and 425.23 bp. The OTUs analysis showed a long tail in the rank abundance curves, indicating that the majority of OTUs were at low abundance, and all the OTUs were evenly distributed (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>OTU rank. In the abscissa, OTUs are sorted according to the number of sequences contained from the most to the least. The ordinate represents the relative abundance of the OTU.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g002.tif"/>
</fig>
</sec>
<sec id="s4_2">
<label>3.2</label>
<title>Comparison of preoperative group with the postoperative group</title>
<sec id="s4_2_1">
<label>3.2.1</label>
<title>Alpha diversity</title>
<p>We compared the Chao1 index, Shannon index, and Simpson index between the preoperative group and the postoperative group. There was no statistical difference in the Chao1 index, Shannon index, and Simpson index between the preoperative group and the postoperative group (<italic>P</italic> &gt; 0.05) (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3</bold>
</xref>&#x2013;<xref ref-type="fig" rid="f5">
<bold>5</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Chao1 index of gut microbiota between the preoperative group and the postoperative group. ns indicates <italic>P</italic> &gt; 0.05; pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g003.tif"/>
</fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Shannon index of gut microbiota between the preoperative group and the postoperative group. ns indicates <italic>P</italic> &gt; 0.05; pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g004.tif"/>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Simpson index of gut microbiota between the preoperative group and the postoperative group. ns indicates <italic>P</italic> &gt; 0.05; pre indicates preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g005.tif"/>
</fig>
</sec>
<sec id="s4_2_2">
<label>3.2.2</label>
<title>Beta diversity</title>
<p>A Bray&#x2013;Curtis NMDS plot (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>) could distinguish samples of preoperative group from the postoperative group significantly. ANOSIM statistical analysis based on Bray&#x2013;Curtis distance algorithm showed that the R<sup>2</sup> value of grouping factors was 0.127, <italic>P</italic> = 0.001.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>A Bray&#x2013;Curtis NMDS plot. pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g006.tif"/>
</fig>
</sec>
<sec id="s4_2_3">
<label>3.2.3</label>
<title>Intestinal microflora structure</title>
<p>At the phylum level, the species with relative abundance of top 15 are shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>. The intestinal microbiota was dominated by <italic>Bacteroidota</italic>, <italic>Bacillota</italic>, <italic>Proteobacteria</italic>, <italic>Actinobacteria</italic>, and <italic>Campilobacterota</italic>. Compared with the preoperative group, the postoperative group had mainly decreased abundance of <italic>Bacteroidota</italic>, <italic>Synergistota</italic>, and <italic>Verrucomimicrobiota</italic> (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>, all <italic>P</italic> &lt; 0.05). Compared with the preoperative group, the postoperative group had mainly increased abundance of <italic>Campylobacter</italic>, <italic>Actinobaciota</italic>, and <italic>Bacillota</italic> (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref> all, <italic>P</italic> &lt; 0.05).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Species with relative abundance of top 15 at the phylum level. pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g007.tif"/>
</fig>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Difference in relative abundance of top 10 bacteria at the phylum level in the preoperative group and the postoperative group. pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g008.tif"/>
</fig>
<p>At the genus level, the species with relative abundance of top 15 are shown in <xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref>. The intestinal microbiota was dominated by&#xa0;<italic>Bacteroides</italic>, <italic>Prevotella</italic>, <italic>Muribaculareae</italic>, <italic>Alistipes</italic>, and <italic>Parabacteroides</italic>. Compared with the preoperative group, the postoperative group had mainly decreased abundance of <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Blautia</italic>, and <italic>Lachnospiraceae_NK4A136_</italic>group (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>, all <italic>P</italic> &lt; 0.05). Compared with the preoperative group, the postoperative group had mainly increased abundance of <italic>Campylobacter</italic>, <italic>Porphyromona</italic>, <italic>Finegoldia</italic>, <italic>Dialister</italic>, <italic>Anaerococcus</italic>, and <italic>Corynebacterium</italic> (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>, all <italic>P</italic> &lt; 0.05).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Species with relative abundance of top 15 at the genus level. pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g009.tif"/>
</fig>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Difference in relative abundance of top 10 bacteria at the genus level in the preoperative group and the postoperative group. pre indicates the preoperative group; post indicates the postoperative group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1533816-g010.tif"/>
</fig>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>There are approximately 10<sup>13</sup>~10<sup>14</sup> microorganisms in the human gut, with a total genome size approximately 100 times that of the human genome (<xref ref-type="bibr" rid="B22">22</xref>). Literature research shows that the changes of intestinal microbial community composition are closely related to diabetes, inflammatory bowel disease, obesity, and other diseases (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Various microorganisms living in the human body actively participate in physiological processes such as immunity, digestion, and toxin degradation in the body and have significant effects on human development and health (<xref ref-type="bibr" rid="B9">9</xref>). However, because of the characteristics of strong metabolism, strong diffusion ability, small individual size, and high mutational rates, it is difficult for traditional pure culture methods to obtain an accurate and comprehensive understanding of the overall situation of microorganisms (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Microbial 16SrDNA high-throughput sequencing explores the relationship between microbes and organisms and between microbes and the natural environment from top to bottom by looking at the genetic information of all microbes in the environment as a whole. It breaks through the technical bottleneck of difficult cultivation of microorganisms and can also be combined with the use of bioinformatics methods to reveal the laws of interaction between microorganisms and the environment; the same is true among microorganisms, greatly broadening the research methods and ideas of microbiology, opening up a new way&#xa0;to re understand the functions and ecological characteristics of&#xa0;microorganisms from the perspective of microbial community structure.</p>
<p>The reconstruction of the digestive tract after surgery for GC has fundamentally changed the intestinal microenvironment, including intestinal oxygen availability, pH, and food transport time. However, the results of this study showed that there was no statistical difference in the Chao1 index, Shannon index, and Simpson index between the preoperative group and the postoperative group (<italic>P</italic> &gt; 0.05). This indicates that surgery does not affect the diversity of fecal microbial species in patients with GC. This result is inconsistent with the results of a study in Japan. According to Erawijantari&#x2019;s research in Japan, &#x3b1; diversity of the postoperative GC group was significantly higher than that of the normal group (<xref ref-type="bibr" rid="B23">23</xref>). The possible reason why this result is inconsistent with this study is that the selection of the control group is different. We selected preoperative patients with GC as the control group, whereas the Japanese study selected normal people as the control group. GC itself has had an impact on the diversity of intestinal flora.</p>
<p>Currently, there are few studies on the impact of GC surgery on the intestinal flora of patients. 16S rRNA gene sequencing was used to evaluate differences in gut microbiota among patients with GC before and after the gastrectomy by comparing gut microbiota &#x3b2; diversity and structure composition at different taxonomic levels. Compared with the preoperative group, the postoperative group had mainly increased abundance of <italic>Campylobacter</italic>, <italic>Actinobaciota</italic>, and <italic>Bacillota</italic> (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>, all <italic>P</italic> &lt; 0.05). Compared with the preoperative group, the postoperative group had mainly decreased abundance of <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Blautia</italic>, and <italic>Lachnospiraceae_NK4A136_</italic>group (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>, all <italic>P</italic> &lt; 0.05). Compared with the preoperative group, the postoperative group had mainly increased abundance of <italic>Campylobacter</italic>, <italic>Porphyromona</italic>, <italic>Finegoldia</italic>, <italic>Dialister</italic>, <italic>Anaerococcus</italic>, and <italic>Corynebacterium</italic> (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref>, all <italic>P</italic> &lt; 0.05).</p>
<p>
<italic>Bacteroides</italic>, <italic>Lachnospiraceae_NK4A136_</italic>group, and <italic>Faecalibacteriu</italic> are potentially beneficial bacteria. Studies have shown that Bacteroides participate in a variety of important metabolic activities in the intestinal tract, including carbohydrate fermentation, the use of nitrogen-containing substances, and the biological transformation of bile acids and other steroids. In addition, <italic>Bacteroides</italic> helps the host resist colonization of intestinal pathogens and volatilize immune regulation, preventing invasion by invasive pathogens (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). <italic>Lachnospiraceae_NK4A136_</italic>group and <italic>Clostridium pratense</italic> in <italic>Faecalibacteriu</italic> are one of the most important bacteria in the human intestinal flora. The acetic acid and butyric acid produced by fermentation have anti-inflammatory effects and maintain bacterial enzyme activity (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). The decrease in abundance of <italic>Lachnospiraceae_NK4A136_</italic>group and <italic>Faecalibacteriu</italic> may be due to surgical stress, leading to GI physiological changes, such as inhibition of gastric acid release, changes in GI motility, and increased production of bicarbonate in the duodenum. These changes are not conducive to the survival, adhesion, and replication of <italic>Bacteroides</italic> and <italic>Spirillum</italic>, resulting in a decrease in their number.</p>
<p>
<italic>Campylobacter</italic> is a typical aerobic bacterium. <italic>Corynebacterium</italic> and <italic>Dialister</italic> are aerobic or facultative anaerobic bacteria. <italic>Porphyromona</italic> is a common microorganism associated with oral diseases. The reconstruction of the digestive tract after surgery for GC has changed the intestinal environment, possibly providing conditions for the growth of aerobic or facultative anaerobes, as well as creating opportunities for the translocation of oral microorganisms (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Many research studies have reported that <italic>Finegoldia</italic> and <italic>Anaerococus</italic> are highly pathogenic conditional pathogens, most of which belong to the Gram-negative group. In addition, <italic>Finegoldia</italic> is one of the most common pathogens in the etiology of post-prosthetic implantation-associated septic arthritis (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), which is enriched after GC surgery, whereas the reduction of <italic>Bacteroides</italic> and <italic>Laclobacteria</italic> increases the chances of infection in patients.</p>
<p>Unfortunately, our study did not detect and analyze changes in the oral flora of patients with GC during the perioperative period. In a systematic review by Maksimaityte et&#xa0;al. (<xref ref-type="bibr" rid="B31">31</xref>), it was mentioned that gastrectomy-induced dysbiosis is characterized by an increase in the number of typical oral bacteria, an increase in the number of oxygen-resistant bacteria (aerobic/parthenogenetic anaerobic), and an increase in the number of bile acid&#x2013;converting bacteria. Due to a certain association between our oral and intestinal flora, the relative abundance of oral colonization in the fecal matter increases when the intestinal flora decreases and is associated with patient prognosis (<xref ref-type="bibr" rid="B32">32</xref>). Therefore, certain oral colonizing bacteria might be able to enter the intestinal lumen by aiding the food digestion process or the gastric tube route, which could be a potential new idea for flora regulation.</p>
<p>This study has some limitations. First, this is a single-center study, and the results may not be generalizable to the entire country. Second, the sample size in this study was small and limited in scope, which warrants further research in a larger sample.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Biomedical Ethics Committee of West China Hospital of Sichuan University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>YH: Methodology, Writing &#x2013; original draft. SG: Methodology, Writing &#x2013; original draft. LJ: Writing &#x2013; review &amp; editing. JY: Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by Sichuan Science and Technology Program (No. 22KPZP0137) and West China Nursing Discipline Development Special Fund Project, Sichuan University (No. HXHL20002).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr" id="abbrev1">
<p>GC, gastric cancer; GI, gastrointestinal; RYGB, Roux-en-Y gastric bypass.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nouri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zayeri</surname> <given-names>F</given-names>
</name>
<name>
<surname>Akbari</surname> <given-names>ME</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between gastric cancer mortality-to-incidence ratio and human development index: evidence from the global burden of disease study 2016</article-title>. <source>Arch Iran Med</source>. (<year>2021</year>) <volume>24</volume>:<page-range>869&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.34172/aim.2021.130</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Cancer statistics in China and United States, 2022: profiles, trends, and determinants</article-title>. <source>Chin Med J (Engl)</source>. (<year>2022</year>) <volume>135</volume>:<page-range>584&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/CM9.0000000000002108</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>lson</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Advances in the treatment of gastric cancer: 2020-2021</article-title>. <source>Curr Opin Gastroenterol</source>. (<year>2021</year>) <volume>37</volume>:<page-range>615&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MOG.0000000000000776</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hillman</surname> <given-names>ET</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Microbial ecology along the gastrointestinal tract</article-title>. <source>Microbes Environ</source>. (<year>2017</year>) <volume>32</volume>:<page-range>300&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1264/jsme2.ME17017</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cabrera-Rubio</surname> <given-names>R</given-names>
</name>
<name>
<surname>Mira</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods</article-title>. <source>Microb Ecol</source>. (<year>2013</year>) <volume>65</volume>:<page-range>763&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00248-013-0192-5</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Western diet feeding influences gut microbiota profiles in apoE knockout mice</article-title>. <source>Lipids Health Dis</source>. (<year>2018</year>) <volume>17</volume>:<fpage>159</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12944-018-0811-8</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khanna</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Microbiota replacement therapies: innovation in gastrointestinal care</article-title>. <source>Clin Pharmacol Ther</source>. (<year>2018</year>) <volume>103</volume>:<page-range>102&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cpt.923</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallardo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Izquierdo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vidal</surname> <given-names>RM</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinctive gut microbiota is associated with diarrheagenic escherichia coli infections in Chilean children</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2017</year>) <volume>7</volume>:<elocation-id>424</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2017.00424</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palleja</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kashani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Allin</surname> <given-names>KH</given-names>
</name>
<etal/>
</person-group>. <article-title>Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota</article-title>. <source>Genome Med</source>. (<year>2016</year>) <volume>8</volume>:<fpage>67</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13073-016-0312-1</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremaroli</surname> <given-names>V</given-names>
</name>
<name>
<surname>Karlsson</surname> <given-names>F</given-names>
</name>
<name>
<surname>Werling</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation</article-title>. <source>Cell Metab</source>. (<year>2015</year>) <volume>22</volume>:<page-range>228&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.009</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Gut microbiota shifts in patients with gastric cancer in perioperative period</article-title>. <source>Med (Baltimore)</source>. (<year>2019</year>) <volume>98</volume>:<fpage>e16626</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000016626</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viaud</surname> <given-names>S</given-names>
</name>
<name>
<surname>Saccheri</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mignot</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide</article-title>. <source>Science</source>. (<year>2013</year>) <volume>342</volume>:<page-range>971&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1240537</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>The effects of preoperative intestinal dysbacteriosis on postoperative recovery in colorectal cancer surgery: a prospective cohort study</article-title>. <source>BMC Gastroenterol</source>. (<year>2021</year>) <volume>21</volume>:<fpage>446</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12876-021-02035-6</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maekawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yoshitani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yahagi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Asahara</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shishido</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fukushima</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between postoperative changes in the gut microbiota and pseudopsia after cardiac surgery: prospective observational study</article-title>. <source>BMC Surg</source>. (<year>2020</year>) <volume>20</volume>:<fpage>247</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12893-020-00907-4</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Lohse</surname> <given-names>M</given-names>
</name>
<name>
<surname>Usadel</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>. (<year>2014</year>) <volume>30</volume>:<page-range>2114&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reyon</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>SQ</given-names>
</name>
<name>
<surname>Khayter</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>FLASH assembly of TALENs for high-throughput genome editing</article-title>. <source>Nat Biotechnol</source>. (<year>2012</year>) <volume>30</volume>:<page-range>460&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nbt.2170</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caporaso</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Kuczynski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Stombaugh</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>QIIME allows analysis of high-throughput community sequencing data</article-title>. <source>Nat Methods</source>. (<year>2010</year>) <volume>7</volume>:<page-range>335&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nmeth.f.303</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rognes</surname> <given-names>T</given-names>
</name>
<name>
<surname>Flouri</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nichols</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>VSEARCH: a versatile open source tool for metagenomics</article-title>. <source>PeerJ</source>. (<year>2016</year>) <volume>4</volume>:<fpage>e2584</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.2584</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Garrity</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Tiedje</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy</article-title>. <source>Appl Environ Microbiol</source>. (<year>2007</year>) <volume>73</volume>:<page-range>5261&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.00062-07</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bunge</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Estimating the number of species in a stochastic abundance model</article-title>. <source>Biometrics</source>. (<year>2002</year>) <volume>58</volume>:<page-range>531&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.0006-341x.2002.00531.x</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>Using ecological diversity measures with bacterial communities</article-title>. <source>FEMS Microbiol Ecol</source>. (<year>2003</year>) <volume>43</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-6941.2003.tb01040.x</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional molecular ecological networks</article-title>. <source>mBio</source>. (<year>2010</year>) <volume>1</volume>:<page-range>e00169&#x2013;00110</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00169-10</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erawijantari</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Mizutani</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles</article-title>. <source>Gut</source> (<year>2020</year>) <volume>69</volume>:<page-range>1404&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2019-319188</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zafar</surname> <given-names>H</given-names>
</name>
<name>
<surname>Saier</surname> <given-names>MH</given-names>
<suffix>Jr</suffix>
</name>
</person-group>. <article-title>Gut Bacteroides species in health and disease</article-title>. <source>Gut Microbes</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19490976.2020.1848158</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname> <given-names>N</given-names>
</name>
<name>
<surname>Emoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yamashita</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis</article-title>. <source>Circulation</source>. (<year>2018</year>) <volume>138</volume>:<page-range>2486&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.033714</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivi&#xe8;re</surname> <given-names>A</given-names>
</name>
<name>
<surname>Selak</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lantin</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut</article-title>. <source>Front Microbiol</source>. (<year>2016</year>) <volume>7</volume>:<elocation-id>979</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2016.00979</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walter</surname> <given-names>G</given-names>
</name>
<name>
<surname>Vernier</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pinelli</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Million</surname> <given-names>M</given-names>
</name>
<name>
<surname>Coulange</surname> <given-names>M</given-names>
</name>
<name>
<surname>Seng</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>. (<year>2014</year>) <volume>33</volume>:<page-range>1355&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10096-014-2073-3</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maksimaityte</surname> <given-names>V</given-names>
</name>
<name>
<surname>Bausys</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kryzauskas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Luksta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stundiene</surname> <given-names>I</given-names>
</name>
<name>
<surname>Bickaite</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Gastrectomy impact on the gut microbiome in patients with gastric cancer: A comprehensive review</article-title>. <source>World J Gastrointest Surg</source>. (<year>2021</year>) <volume>13</volume>:<page-range>678&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4240/wjgs.v13.i7.678</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Rolling</surname> <given-names>T</given-names>
</name>
<name>
<surname>Djukovic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fei</surname> <given-names>T</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>V</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes</article-title>. <source>Nat Microbiol</source>. (<year>2024</year>) <volume>9</volume>:<page-range>1555&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-024-01680-3</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Ley</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Mahowald</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>444</volume>:<page-range>1027&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature05414</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>. <source>Nature</source>. (<year>2012</year>) <volume>490</volume>:<fpage>55</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature11450</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youssef</surname> <given-names>O</given-names>
</name>
<name>
<surname>Lahti</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kokkola</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Stool microbiota composition differs in patients with stomach, colon, and rectal neoplasms</article-title>. <source>Dig Dis Sci</source>. (<year>2018</year>) <volume>63</volume>:<page-range>2950&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10620-018-5190-5</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>